|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1083271035 |
003 |
OCoLC |
005 |
20231120010337.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
190125s2019 moua ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d N$T
|d EBLCP
|d N$T
|d UKMGB
|d YDXIT
|d OCLCF
|d OCLCO
|d OCLCQ
|d OPELS
|d OCLCQ
|d OPELS
|d S2H
|d LVT
|d UX1
|d VT2
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBB915538
|2 bnb
|
015 |
|
|
|a GBB913816
|2 bnb
|
016 |
7 |
|
|a 019221835
|2 Uk
|
019 |
|
|
|a 1083117925
|a 1083464770
|a 1229721608
|a 1235823921
|
020 |
|
|
|a 9780128167410
|q (electronic bk.)
|
020 |
|
|
|a 0128167416
|q (electronic bk.)
|
020 |
|
|
|a 9780128164297
|q (electronic bk.)
|
020 |
|
|
|a 0128164298
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)1083271035
|z (OCoLC)1083117925
|z (OCoLC)1083464770
|z (OCoLC)1229721608
|z (OCoLC)1235823921
|
050 |
|
4 |
|a QP772.B55
|b D37 2019
|
060 |
|
4 |
|a 2019 C-841
|
060 |
|
4 |
|a QU 195
|
072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
082 |
0 |
4 |
|a 612.0157
|2 23
|
100 |
1 |
|
|a Dasgupta, Amitava,
|d 1958-
|e author.
|
245 |
1 |
0 |
|a Biotin and other interferences in immunoassays :
|b a concise guide /
|c Amitava Dasgupta.
|
264 |
|
1 |
|a St. Louis, Missouri :
|b Elsevier,
|c [2019]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed January 30, 2019)
|
520 |
|
|
|a Biotin and Other Interferences in Immunoassays: A Concise Guide is aimed at clinical laboratory scientists, medical technologists and pathologists who are often the first individuals contacted by a clinician when a laboratory test result does not correlate with clinical presentation. Research scientists working in diagnostics companies will also find this information essential. Sources of errors in non-immunoassay based methods used in clinical chemistry and toxicology laboratory are also discussed so readers can get all important information from one concise guide. This succinct, user-friendly reference provides the necessary information to address high levels of biotin in clinical laboratory results.
|
650 |
|
0 |
|a Biotin.
|
650 |
1 |
2 |
|a Biotin
|0 (DNLM)D001710
|
650 |
2 |
2 |
|a Immunoassay
|x methods
|0 (DNLM)D007118Q000379
|
650 |
|
6 |
|a Biotine.
|0 (CaQQLa)201-0066558
|
650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
650 |
|
7 |
|a Biotin
|2 fast
|0 (OCoLC)fst00832854
|
776 |
0 |
8 |
|i Print version:
|a Dasgupta, Amitava, 1958-
|t Biotin and other interferences in immunoassays.
|d St. Louis, Missouri : Elsevier, [2019]
|z 9780128164297
|w (OCoLC)1044853538
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128164297
|z Texto completo
|